Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients

Oncology Clinical Trial

Official title:

Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03951090
• Other study ID #: LCCC 1538
• Status: Completed
• Phase: N/A
• Start date: April 25, 2016
• Est. completion date: April 24, 2018

Study information

• Verified date: May 2019
• Source: UNC Lineberger Comprehensive Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study prospectively evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in a cohort of non-electively hospitalized older (> 70 years) adults with cancer.

Description:

This study evaluates the impact of geriatric assessment reporting in real-time (GARRT) on key hospital based outcomes in non-electively hospitalized older (> 70 years) adults with cancer. Participants will be randomly assigned to the GARRT group, or the control group. All participants will fill out user friendly questionnaire called the geriatric assessment. The results of the geriatric assessment will be given to the physicians of participants in the GARRT group in real-time. The physicians of participants in the control group will not receive real time results.

This study will compare the referral rates of participants in each group to determine if providing real-time results of the geriatric assessment impact referral rates.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 148
• Est. completion date: April 24, 2018
• Est. primary completion date: April 24, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 70 Years and older

Eligibility

Inclusion Criteria:

• Age 70 years or older.

• English speaking.

• Admitted to UNC Hospitals non-electively within 72 hours.

• Biopsy proven solid tumor or myeloma or lymphoma.

• Newly diagnosed cancer patients for whom active cancer directed therapy is planned within the next six months or patients on active cancer directed therapy either currently or within the previous 6 months.

• Signed written IRB-approved informed consent.

Exclusion Criteria:

• Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation. Patients with a life expectancy <6 weeks

• Patients who are <48 hours post-surgery.

• Patients who are admitted to an intensive care setting.

• Patients with acute myeloma lymphoma (AML) or other high grade hematologic malignancies.

• Patients undergoing bone marrow transplant or admitted to the bone marrow transplant unit.

Related Conditions & MeSH terms

• Oncology

Intervention

Other:
• Results of the brief geriatric assessment
Providers will receive results of the brief geriatric assessment with recommendations for address deficits identified through the results of the brief geriatric assessment
• No results of brief geriatric assessments
Providers will not receive results of the brief geriatric assessment. Participants will receive standard of care treatment

Locations

Country	Name	City	State
United States	UNC Lineberger Comprehensive Cancer Center	Chapel Hill	North Carolina

Sponsors (1)

Lead Sponsor	Collaborator
UNC Lineberger Comprehensive Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Referral rate for GA-identified deficits in intervention and control groups	Number of participants with at least one referral for a GA-idenfied deficit	2 years
Secondary	Referral to Physical and Occupational therapy	Number of times physical and occupation therapy referral was given in Intervention and Control group	2 years
Secondary	Referral to Geriatic Consultation	Number of times a Geriatric Consultation referral was given in Intervention and Control group	2 years
Secondary	Referral to Clinical Pharmacist	Number of times Clinical Pharmacist referral was given in Intervention and Control group	2 years
Secondary	Referral to Nutritionist	Number of times Nutritionist referral was given in Intervention and Control group	2 years
Secondary	Referral to psyhcosocial support team	Number of times psychosocial support referral was given in Intervention and Control group	2 years
Secondary	Physician Reported New information	Number of times physicians answer "yes" to the questions "did report provide new information about patient deficits that would warrant a referral"	2 years
Secondary	Physician Reported Satisfaction	Number of times physician indicate "yes" report was helpful when asked "Is this report useful"	2 years